Bardago, Baby Girl .

HRN: 23-72-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
CEFUROXIME 750MG (VIAL)
09/23/2023
09/30/2023
IVTT
200mg
Q8
PCAP C, RAT CONFIRMED COVID PNEUMONIA
Waiting Final Action 
09/23/2023
CEFTRIAXONE 1G (VIAL)
09/23/2023
09/30/2023
IVTT
450mg
OD
PCAP C, RAT CONFIRMED COVID PNEUMONIA
Waiting Final Action 
09/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/23/2023
09/30/2023
IV
60
Q24
PCAP; RAT CONFIRMED COVID PNEUMONIA
Waiting Final Action 
09/25/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/25/2023
10/02/2023
IV
300mg
Q6h
Covid 19 Pneumonia
Waiting Final Action 
09/25/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/25/2023
10/02/2023
IV
450mg
Q6h
Covid 19 Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: